ITC Begins Yet Another Section 337 Investigation on Hydrodermabrasion Systems
The International Trade Commission is beginning a third Section 337 investigation on more allegations from HydraFacial that imports of hydrodermabrasion systems infringe on its patents, the ITC said in a notice Sept. 13. This time, the investigation targets Germany-based MIRAmedtech…
Sign up for a free preview to unlock the rest of this article
Communications Daily is required reading for senior executives at top telecom corporations, law firms, lobbying organizations, associations and government agencies (including the FCC). Join them today!
and its Polish and U.S. affiliates, which allegedly are manufacturing and importing the Cleopatra and MIRApeel systems. HydraFacial alleged in August that they infringe on patents related to HydroFacial’s Syndeo hydrodermabrasion system. The investigation also targets Medical Purchasing Resource (MPR), which distributes the Cleopatra system, as well as Clarion, Luvo and Healthcare Markets (d/b/a Powered by MRP), which distribute Eunsung’s Bela MD hydrodermabrasion system, and Bio-Infusions USA. The ITC will consider whether to issue a limited exclusion order and cease and desist orders against the respondents.